Update on Chronic Lymphocytic Leukemia with data from ASH
Susan O’Brien, MD of UC Irvine Health Chao Family gives an update of Chronic Lymphocytic Leukemia with data from ASH 2015 at Spotlight on ASH Thursday, January 28, 2016 Fairmont Newport Beach Author: moasc Added: 01/29/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 29, 2016 Category: Cancer & Oncology Source Type: podcasts

ASH 2015 highlights by Prof. Michael Hallek
Michael Hallek, MD from the University of Cologne, Cologne, Germany, provides an overview of main chronic lymphocytic leukemia (CLL) studies being presented at the America Society of Hematology (ASH) ... Author: VJHemOnc Added: 01/27/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 27, 2016 Category: Cancer & Oncology Source Type: podcasts

Why is it important to stay informed as a CLL patient?
Prof. Thomas Kipps talks about the importance of having an advocate that can support you through your chronic lymphocytic leukemia (CLL) journey as a patient. He also discusses the importance of recog... Author: PatientPowerEU Added: 01/25/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 25, 2016 Category: Cancer & Oncology Source Type: podcasts

New targeted therapies in chronic lymphocytic leukaemia (CLL)
Prof. Peter Hillmen from St. James’ University Hospital, Leeds, UK, gives an overview of the new targeted therapies for chronic lymphocytic leukaemia (CLL). Data presented at ASH 2015 demonstrates the... Author: PatientPowerEU Added: 01/25/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 25, 2016 Category: Cancer & Oncology Source Type: podcasts

Clinical trials in CLL and patient support groups
Prof. Peter Hillmen from St. James' University Hospital, Leeds, UK, discusses the treatment options for chronic lymphocytic leukaemia (CLL) patients, including drugs being tested in clinical trials. P... Author: PatientPowerEU Added: 01/19/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 19, 2016 Category: Cancer & Oncology Source Type: podcasts

How can clinical trials help you manage CLL?
At the America Society of Hematology (ASH) 2015 Annual Meeting, in Orlando, FL, Prof. Thomas Kipps talks about clinical trials in chronic lymphocytic leukemia (CLL). He describes the importance of par... Author: PatientPowerEU Added: 01/18/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 18, 2016 Category: Cancer & Oncology Source Type: podcasts

Why is it important to stay informed as a CLL patient?
Prof. Thomas Kipps talks about the importance of having an advocate that can support you through your chronic lymphocytic leukemia (CLL) journey as a patient. He also discusses the importance of recog... Author: PatientPowerEU Added: 01/18/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 18, 2016 Category: Cancer & Oncology Source Type: podcasts

Overview of the clinical trial of ibrutinib vs chlorambucil as front-line therapy
Véronique Leblond, MD, PhD from the Hospital of Pitié Salpêtrière, Paris, France, provides an overview if the Phase III clinical trial of ibrutinib vs chlorambucil in chronic lymphocytic leukemia (CLL... Author: VJHemOnc Added: 01/13/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 13, 2016 Category: Cancer & Oncology Source Type: podcasts

How far are we from a cure for CLL?
Thomas J Kipps, MD from the University of California, San Diego, CA, discussed the current treatment landscape in chronic lymphocytic leukemia (CLL), considering the novel therapies being presented at... Author: VJHemOnc Added: 01/13/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 13, 2016 Category: Cancer & Oncology Source Type: podcasts

Ibrutinib vs chlorambucil in CLL patients not suitable for chemotherapy
Thomas J Kipps, MD from the University of California, San Diego, CA, provides an overview of the clinical trial RESONATE-2 comparing ibrutinib with chlorambucil in chronic lymphocytic leukemia (CLL) p... Author: VJHemOnc Added: 01/13/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 13, 2016 Category: Cancer & Oncology Source Type: podcasts

The importance of targeting proliferating and quiescent cells in CLL
Peter Hillmen, MBChB, PhD from St. James' University Hospital, Leeds, UK, discusses the importance of targeting proliferanting and quiescent chronic lymphocytic leukemia (CLL) cells. Recorded at the ... Author: VJHemOnc Added: 01/13/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 13, 2016 Category: Cancer & Oncology Source Type: podcasts

Can we aford to have CLL patients on a therapy for the rest of their lifes?
At the American Society of Hematology (ASH) 2015 Annual Meeting, John Gribben, MD, DSc and Stephan Stilgenbauer, MD discuss the use of ibrutinib as front-line therapy in chronic lymphocytic leukemia (... Author: VJHemOnc Added: 01/13/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 13, 2016 Category: Cancer & Oncology Source Type: podcasts

Overview of Resonate-2 clinical trial of ibrutinib in CLL
At the American Society of Hematology (ASH) 2015 Annual Meeting, John Gribben, MD, DSc and Stephan Stilgenbauer, MD discuss the use of ibrutinib as front-line therapy in chronic lymphocytic leukemia (... Author: VJHemOnc Added: 01/13/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 13, 2016 Category: Cancer & Oncology Source Type: podcasts

Overview of two clinical trials of ibrutinib and venetoclax in chronic lymphocytic leukemia
Barbara Eichhorst, MD from the Ludwig-Maximilians University, Munich, Germany, provides an overview of combination studies presented at the American Society of Hematology (ASH) 2015 Annual Meeting hel... Author: VJHemOnc Added: 01/13/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 13, 2016 Category: Cancer & Oncology Source Type: podcasts

CLL Town Meeting Afternoon Session Replay in Houston, Texas
Watch the replay of the afternoon session of the town meeting, “Living Well with Chronic Lymphocytic Leukemia: Education, Empowerment and Learning from Others,” as leading experts and powerful patient... Author: patientpower Added: 01/11/2016 (Source: Oncology Tube)
Source: Oncology Tube - January 11, 2016 Category: Cancer & Oncology Source Type: podcasts